Introduction-The eVects of an intensive training programme involving screening of children for disorders of growth and puberty for community based nursing and medical staV employed by CardiV Community Healthcare NHS Trust were audited to assess the impact of this training on referrals to the local hospital based growth clinic. Method-Referrals from community based staV to the growth clinic of patients living in the geographical area in which staV underwent training were compared with those from general practitioners in the 18 months prior to and following the training programme. Hospital notes were available for 209 of 254 (82.2%) patients identified. We excluded 112 referrals as they did not have a problem relating to growth or puberty or were inter-hospital referrals. Hence 97 referrals were included in the final audit. Results-Forty referrals occurred prior to compared with 57 following the training programme. The number of referrals from community based staV increased threefold during the six months immediately following the training programme but then returned to the previous level. There were no diVerences in age or height standard deviation scores at referral between groups at any time. The proportion of children referred from the community with significant abnormalities of growth or puberty (for example, hypothyroidism or precocious puberty) increased from two of 15 referrals to six of 30 referrals following the training programme. Conclusions-Intensive training in screening for disorders of growth and puberty can increase the number of referrals of children with significant pathology but at the cost of increased total number of referrals. The increase in referrals is not sustained with time, suggesting continued training is necessary. (J Med Screen 2001;8:15-17) 
Screening for disorders of growth and puberty has been recommended as a means of recognising unidentified medical and social disorders. 1 Current recommendations suggest that repeated measurements of height on at least four occasions between 18 months and nine years of age are desirable. 1 The shorter the child's stature the more likely it is that the child is not growing normally 2 and that investigation may reveal underlying pathology. Previous population studies have shown that 17-21% of children with heights below the third centile had organic disease of which 20% was previously undiagnosed. 3 Early diagnosis and remedial treatment of conditions leading to short stature provides a better prognosis for final adult height. 4 Adherence to the current recommendations has not been shown to result in an excess of inappropriate referrals 5 when measurements are undertaken by trained personnel. However, recently doubt has been cast on the benefit of these repeated measurements 6 based on evidence from the Wessex growth study that has been monitoring a cohort of very short children in the community. 7 This study failed to show any benefit from repeated measurements and suggests one measurement at school entry would be the most sensitive indicator of underling disease. 8 In CardiV, children are routinely screened for height at school entry and a previous audit showed that the availability of appropriate equipment and measuring skills were poor. As a result, in May 1996 an intensive training programme in screening for disorders of growth and puberty for community based nursing and medical staV working for CardiV Community Healthcare NHS Trust was undertaken. An audit was subsequently carried out to assess the eVect of this training on the number of referrals, quality of data contained within the referral letters, and final diagnoses of patients referred to the local hospital based growth and endocrine clinic.
Method
The hospital clinical growth service serving the city of CardiV and surrounding areas is based at the University Hospital of Wales, CardiV. The growth clinic acts as both the secondary referral centre for local children in the CardiV area and a tertiary referral service for children throughout South and Mid Wales. The clinic is staVed by a consultant senior lecturer in paediatric endocrinology, a visiting consultant paediatrician, a senior registrar in paediatric endocrinology, a lecturer in paediatric endocrinology, a staV grade doctor, and an auxologist.
In May 1996, at the request of the consultants in paediatric endocrinology and community paediatrics, the Child Growth Foundation staged three one day courses in CardiV to train community nurses (health visitors and school nurses) and community paediatricians in the assessment of children's growth. The training programme was held on consecutive days. On each of these days practical instruction was given in the techniques and equipment to be used for supine and standing measurements. A further session was devoted to the importance of plotting measurement data correctly on centile charts and using mid parental height data to assist in the detection of growth abnormalities. Two lectures then summarised the medical conditions likely to result in abnormalities of growth.
The audit was undertaken to compare referrals to the hospital growth clinic of children resident in the geographical area covered by CardiV Community Healthcare NHS Trust in the 18 months prior to the training programme (1 November 1994 to 30 April 1996) with those in the following 18 months (1 June 1996 to 30 November 1997). Referrals in May 1996 when the training programme was being undertaken were excluded, as it was not clear if these had been influenced by staV who had attended the training programme. Referral numbers for each 18 month period were divided into three six monthly periods to detect temporal changes in referral patterns following the training programme. Referrals were identified from a clinic database.
A total of 254 referrals of children living within the area in which community services are provided by CardiV Community Healthcare NHS Trust were identified from the database as being potentially eligible for the audit. Two hundred and nine (82.2%) clinic notes were available for audit. Forty five sets of notes could not be found. We excluded 112 further referrals from the audit for the following reasons: (1) patients had diagnoses that did not have major influences on weight, growth, or puberty, which were the topics specifically covered in the training programme; (2) the date of referral was outwith the specified period; (3) the notes were incomplete; (4) patients were inter-hospital referrals.
Ninety seven referrals were included in the final audit. Prior to the audit it was agreed that certain standard information should ideally be included within the referral letter, including height, weight, height velocity (or comments about height crossing centiles), age, parental height, stage of puberty, drug treatment, and any other significant factors associated with growth failure.
Referrals from community based medical and nursing staV were compared with those received from general practitioners (GPs). It was anticipated that GP referrals would act as appropriate controls to assess the eVect of training of community staV, as GPs had not been invited to the training programme.
Changes in referral patterns were compared using either the 2 or Fisher's exact tests. DiVerences in age and height standard deviation scores at referral between the groups were compared using independent sample t tests.
Results
There was almost no change in the number of referrals in each six month period prior to the training programme (table 1). In the six months following the training package, referrals from community based staV increased threefold but then returned to previous levels (table 1). Twice as many referrals were received from community based staV over the 18 months following the training programme than in the previous period, whereas the number of GP referrals remained stable.
The increase in referrals from the community based staV was predominantly for children with familial short stature. Twenty two children referred from the community after the training programme had this diagnosis compared with 11 prior to training. Eleven and 15 children, respectively, were referred by GPs with this diagnosis over the same periods. Two children with constitutional delay in growth and puberty were referred by community staV prior to training compared with one after the programme. No child referred by GPs had this diagnosis prior to the training programme but two did thereafter.
There was a threefold increase in the numbers of patients who were diagnosed as having pathologically abnormal growth or puberty referred by community staV after the training programme (table 1) whereas similar referrals from GPs increased twofold over the same time period. This increase was not statistically significant, probably due to the small numbers involved. The significant pathologies diagnosed in those referred prior to the training programme were gonadal dysgenesis (aged 17.2 years) referred by a GP, and coeliac disease (8.1 years) and hypogonadotrophic hypogonadism (11.7 years) referred by community staV. In the time period following the training session, GPs referred a child with hypogonadotrophic hypogonadism (15.4 years) and micropenis (14.9 years). Community based staV referred children with hypothyroidism (two patients aged 2.7 and 13.5 years), isolated growth hormone deficiency (12.7 years), central precious puberty (9.2 years), Prader Willi syndrome (16.5 years), and a .35) ). Some changes were seen in the information included in the referral letters following the training programme. Height velocity and age were mentioned more frequently in the referrals from the community following the training programme (included in 40% and 33%, respectively, of letters prior to the training programme and 56% and 46%, respectively, of letters following the training programme) but actual height, weight, and parental heights were mentioned less frequently (100%, 66%, and 53%, respectively, prior to the training programme and 80%, 56%, and 46%, respectively, following the training programme).
Discussion
Although there has been debate recently about the extent and validity of growth monitoring or height screening, 6 there is widespread agreement that attempts should be made to identify children with abnormal growth. This study was small and undertaken over a relatively short period of time so caution must be applied to the interpretation of the results. Nevertheless, we have shown that an intensive training programme in growth and puberty transiently increases the number of children referred from a community based service to a hospital based growth clinic for assessment, although the increase was not statistically significant, probably due to the small numbers involved. The increase in referrals occurred in the six months immediately following the training programme and the referral rate subsequently returned to pre-training levels thereafter. This suggests that the training programme was eVective in assisting staV to identify children with important abnormalities of growth and puberty but that the eVect was short lived and continued training may be necessary. Interestingly, as well as an increase in the total number of referrals, the proportion of children referred with significant underlying pathology was also increased, suggesting an improvement in the appropriateness of referrals. However, the number of children with underlying pathology was small and hence this increased rate should be interpreted with caution.
There was no diVerence in age or height SDS of children referred before or after training, suggesting that the training programme was not resulting in children being identified earlier in the course of illnesses which ultimately result in an adverse eVect on growth but rather that more children were being identified. It has been suggested that a single measurement at school entry is the most sensitive marker of underlying disease. 8 Although this may be true, a significant proportion of children referred in our audit were teenagers and had abnormalities related to puberty and the pubertal growth spurt. This finding suggests that continued vigilance is necessary throughout childhood and that significant concerns about growth or pubertal development should stimulate referral at any age.
Although there was an increase in the number of children with underlying pathology referred from community staV following the training programme, most of the extra referrals were healthy children, often with familial short stature, who required no treatment. Although reassurance may well be necessary in these individuals, this could be given by the person carrying out the initial measurement and assessment rather than necessitating referral to a "growth clinic". Referral in these individuals may temporally increase anxiety unnecessarily and should be avoided where possible. This general increase in referrals may have resource implications for growth clinics which provide secondary referral services for areas in which such training has occurred and also suggests that further improvement in the quality of the training packages is required.
The information contained in the referral letter changed in some respects following the training programme. Height velocity was included more often, as the importance of abnormalities in growth rate had clearly been emphasised at the training programme, but actual height and weight were included less often. This is disappointing as these data are helpful in interpreting the urgency of referral.
This study has demonstrated that intensive training in growth and puberty increases the number of referrals of children with significant underling pathology but at the cost of increased total number of referrals. The increase in referrals is not sustained and continued training is necessary.
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